
    
      This is a study to evaluate the safety, feasibility and efficacy of CAR-T cell therapy in the
      treatment of relapsed or refractory multiple myeloma.

      The Main research objectives:

      To evaluate the safety and efficacy of CAR-T cell therapy in patients with relapsed or
      refractory multiple myeloma.

      The Secondary research objectives:

      To evaluate the safety and efficacy of CAR-T cell therapy in patients with relapsed or
      refractory multiple myeloma.
    
  